ELLEN BATTISTA: Open Payments
NPI 1780770024 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 9 payments from 9 companies in 2025. Trend: 2023 $523 · 2024 $795 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $145 |
| Amgen Inc. | 1 | $130 |
| Grifols USA, LLC | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Corcept Therapeutics | 1 | $111 |
| Eisai Inc. | 1 | $102 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $48 |
Products named: KRYSTEXXA, Prolastin-C Liquid, INGREZZA, Wegovy, Korlym.
Industry payments across NY — which companies pay providers there.
